EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessing DCLK1, SOX2, and KI67 protein expression via immunohistochemistry in epithelial colorectal tumors: an Egyptian observation

Sara E. Khalifa, Somia A.M. Soliman, Mohamed E. Mohamed

Egyptian Journal of Pathology · 2026-01 · 46 (1) · 63-69

DOI: 10.4103/egjp.egjp_29_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Pathology, online erschienen am 21.07.2026. Verfasst von Sara E. Khalifa und 2 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective Colorectal cancer is a significant global health concern, with a complex progression from adenomas to malignancy. This study investigates the immunohistochemical expression of Doublecortin-like kinase 1 (DCLK1) and SOX2, and their correlation with the proliferation marker KI67, in colorectal neoplasms.

Methods

The study included 80 cases of colonic neoplasms (50 colorectal carcinomas and 30 adenomas). Immunohistochemical staining was performed for DCLK1, SOX2, and KI67, and the expression levels were correlated with clinicopathological features.

Results

DCLK1 was overexpressed in colorectal carcinoma compared to adenomas, with high expression associated with larger tumor size, advanced staging, and lymphocytic infiltration. SOX2 was also more highly expressed in carcinoma cases. Less than 20% positive nuclear immunostaining of KI67 was seen in 19 (38%) of CRC cases and more than 20% was noted in 31 (62%) cases.

Conclusion

The differential expression of DCLK1 and SOX2 between colorectal carcinoma and adenoma, highlighted their potential as valuable biomarkers in colorectal neoplasia. The overexpression of DCLK1 in colorectal carcinoma, significantly associated with larger tumor size, advanced staging, and inversely with lymphocytic infiltration, suggests its critical involvement in tumor progression and the tumor microenvironment’s immune response. Furthermore, the increased expression of SOX2 in carcinoma compared to adenoma supports its role in the malignant transformation of colorectal cells. Collectively, these findings underscore the potential of DCLK1 and SOX2, along with KI67, to serve as diagnostic and prognostic indicators, offering the promise of improved risk stratification and the development of more tailored and effective therapeutic strategies for colorectal cancer patients.

Zitieren

APA

Khalifa, S. E., Soliman, S. A., & Mohamed, M. E. (2026). Assessing DCLK1, SOX2, and KI67 protein expression via immunohistochemistry in epithelial colorectal tumors: an Egyptian observation. Egyptian Journal of Pathology, 46(1), 63-69. https://doi.org/10.4103/egjp.egjp_29_25

Vancouver

Khalifa SE, Soliman SA, Mohamed ME. Assessing DCLK1, SOX2, and KI67 protein expression via immunohistochemistry in epithelial colorectal tumors: an Egyptian observation. Egyptian Journal of Pathology. 2026;46(1):63-69. doi:10.4103/egjp.egjp_29_25

BibTeX
@article{Khalifa2026,
  author = {Khalifa, Sara E. and Soliman, Somia A.M. and Mohamed, Mohamed E.},
  title = {Assessing DCLK1, SOX2, and KI67 protein expression via immunohistochemistry in epithelial colorectal tumors: an Egyptian observation},
  journal = {Egyptian Journal of Pathology},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {63--69},
  doi = {10.4103/egjp.egjp_29_25}
}
Kostenlos starten →